These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16168529)

  • 1. Evidence for adjuvanticity of anthrax edema toxin.
    Quesnel-Hellmann A; Cleret A; Vidal DR; Tournier JN
    Vaccine; 2006 Feb; 24(6):699-702. PubMed ID: 16168529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthrax edema factor potency depends on mode of cell entry.
    Hong J; Beeler J; Zhukovskaya NL; He W; Tang WJ; Rosner MR
    Biochem Biophys Res Commun; 2005 Sep; 335(3):850-7. PubMed ID: 16099427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-function analysis of Bacillus anthracis edema factor by using monoclonal antibodies.
    Little SF; Leppla SH; Burnett JW; Friedlander AM
    Biochem Biophys Res Commun; 1994 Mar; 199(2):676-82. PubMed ID: 8135809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an edema factor-mediated cAMP-induction bioassay for detecting antibody-mediated neutralization of anthrax protective antigen.
    Zmuda JF; Zhang L; Richards T; Pham Q; Zukauskas D; Pierre JL; Laird MW; Askins J; Choi GH
    J Immunol Methods; 2005 Mar; 298(1-2):47-60. PubMed ID: 15847796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and analysis of biological activity of the recombination anthrax edema factor].
    Dong DY; Xu JJ; Song XH; Fu L; Chen W
    Wei Sheng Wu Xue Bao; 2005 Jun; 45(3):459-62. PubMed ID: 15989247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of mouse polyclonal and human monoclonal antibodies against Bacillus anthracis toxin.
    Huber M; Vor Dem Esche U; Grunow R; Bessler WG
    Drugs Exp Clin Res; 2005; 31(2):35-43. PubMed ID: 15929604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
    Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
    Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased potency of BioThrax anthrax vaccine with the addition of the C-class CpG oligonucleotide adjuvant CPG 10109.
    Gu M; Hine PM; James Jackson W; Giri L; Nabors GS
    Vaccine; 2007 Jan; 25(3):526-34. PubMed ID: 16973247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants.
    Berthold I; Pombo ML; Wagner L; Arciniega JL
    Vaccine; 2005 Mar; 23(16):1993-9. PubMed ID: 15734073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG oligonucleotides improve the protective immune response induced by the licensed anthrax vaccine.
    Klinman DM; Xie H; Ivins BE
    Ann N Y Acad Sci; 2006 Oct; 1082():137-50. PubMed ID: 17145935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the immune response induced by a nasal anthrax vaccine based on the protective antigen protein in anaesthetized and non-anaesthetized mice.
    Sloat BR; Cui Z
    J Pharm Pharmacol; 2006 Apr; 58(4):439-47. PubMed ID: 16597361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal immunization with a dual antigen anthrax vaccine induced strong mucosal and systemic immune responses against toxins and bacilli.
    Sloat BR; Cui Z
    Vaccine; 2006 Sep; 24(40-41):6405-13. PubMed ID: 16828937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Western blot analysis of the exotoxin components from Bacillus anthracis separated by isoelectric focusing gel electrophoresis.
    Little SF
    Biochem Biophys Res Commun; 2004 Apr; 317(1):294-300. PubMed ID: 15047182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthrax toxin-induced shock in rats is associated with pulmonary edema and hemorrhage.
    Kuo SR; Willingham MC; Bour SH; Andreas EA; Park SK; Jackson C; Duesbery NS; Leppla SH; Tang WJ; Frankel AE
    Microb Pathog; 2008 Jun; 44(6):467-72. PubMed ID: 18222626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contributions of edema factor and protective antigen to the induction of protective immunity by Bacillus anthracis edema toxin as an intranasal adjuvant.
    Duverger A; Carré JM; Jee J; Leppla SH; Cormet-Boyaka E; Tang WJ; Tomé D; Boyaka PN
    J Immunol; 2010 Nov; 185(10):5943-52. PubMed ID: 20952678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Toxin-neutralizing monoclonal antibodies to the different domains of anthrax protective antigen].
    Xu JJ; Zhang J; Liu SL; Lv TJ; Chen W; Li GL; Ge M; Guo Q
    Wei Sheng Wu Xue Bao; 2005 Dec; 45(6):947-51. PubMed ID: 16496709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthrax oedema toxin induces anthrax toxin receptor expression in monocyte-derived cells.
    Maldonado-Arocho FJ; Fulcher JA; Lee B; Bradley KA
    Mol Microbiol; 2006 Jul; 61(2):324-37. PubMed ID: 16856939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Femtomolar detection of the anthrax edema factor in human and animal plasma.
    Duriez E; Goossens PL; Becher F; Ezan E
    Anal Chem; 2009 Jul; 81(14):5935-41. PubMed ID: 19522516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induced strong antibody responses against all three antigens.
    Sloat BR; Shaker DS; Le UM; Cui Z
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):169-79. PubMed ID: 18194342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of biologically active Bacillus anthracis edema factor in Escherichia coli.
    Cooksey BA; Sampey GC; Pierre JL; Zhang X; Karwoski JD; Choi GH; Laird MW
    Biotechnol Prog; 2004; 20(6):1651-9. PubMed ID: 15575695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.